Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-075233
Filing Date
2021-06-01
Accepted
2021-06-01 19:16:26
Documents
1
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2118079d2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2118079d2_4seq1.xml 4 3973
  Complete submission text file 0001104659-21-075233.txt   5355
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 665 STOCKTON DRIVE, SUITE 300 C/O IMMUNOME, INC. EXTON PA 19341
Business Address
Giesing Dennis H (Reporting) CIK: 0001853622 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 21987102